CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 1, 2024 · earnings

INMB earnings: a negative outcome, -7.9%

On August 1, 2024, INmune Bio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.9% in the window around the event.

The move

$8.59
1d before
$7.91
Event day
$8.17
1d after
$7.17
5d after

Pre-catalyst setup

+3.5%
30-day run-up
6636%
30-day volatility
0.6×
volume spike